Komura et al. (84) retrospectively analyzed the data from 308 epithelial ovarian cancer patients and found that regardless of the clinical-stage or the rate of reductive surgery, elevated CRP/Alb remained an independent predictor of short-term disease-specific survival. The gene discussed is ALB; the disease is ovarian carcinoma.